AstraZeneca, the UK's second largest drugs company, has announced it is buying California-based Pearl Therapeutics in a deal worth up to $1.15bn (£742m). Privately-owned Pearl specialises in drugs used in the treatment of lung disease and asthma. via Pocket http://www.bbc.co.uk/news/business-22838319#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa
No comments:
Post a Comment